Dr. Baccus's lab studies how the circuitry of the retina translates the visual scene into electrical impulses in the optic nerve.

Dr. Riitta Katila is the W. M. Keck Sr. Professor of Management Science, Faculty Director of the Stanford Technology Ventures Program and HAI Sabbatical Scholar at Stanford Institute for Human-Centered Artificial Intelligence at Stanford University. Her research is in the intersection of technology strategy and organizational learning, using machine learning, statistical analysis and mixed methods.

Dr. Kanan develops new catalysts and chemical reactions for applications in renewable energy conversion and CO₂ utilization.

Dr. Kamaya's current research is in photoacoustic imaging of cancer and perfusion CT imaging of abdominal tumors.

Dr. Ji's research group has embarked on a research initiative to use cutting edge genetics and technology to interrogate the fundamental genetic "digital" code responsible for cancer development and overall clinical behavior.

Dr. Jeffrey's research currently involves extracting and profiling circulating tumor cells (CTCs) from blood and bone marrow to shed light on the metastatic process and eventually to help guide selection of appropriate therapies in individual cancer patients.

Dr. Jarosz's aim is to identify and characterize these mechanisms at the molecular level, integrating our findings to gain insight into the interplay among genetic variation, phenotypic diversity, and environmental fluctuations in complex cellular systems.

Dr. Jardetzky's laboratory is studying the structures and mechanisms of macromolecular complexes important in viral pathogenesis, allergic hypersensitivities and the regulation of cellular growth and differentiation, with an interest in uncovering novel conceptual approaches to intervening in disease processes.

The overarching goal of the research in Dr. Axelrod's lab is to understand how signal transduction pathways regulate morphogenesis - the emergence of spatial organization - during development.

Dr. Attardi's research is aimed at dissecting the mechanism of p53 action and the role of target genes it activates in apoptosis and tumor suppression, using the mouse as a model system.